StockWatch
·

SAMRAT PHARMACHEM LTD.-$ Q4 FY26 Results

SAMRATPHQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue71.7713.2%0.8%
Total Income71.4712.0%0.5%
Expenditure73.3413.9%2.6%
PBT-1.87230.3%415.4%
Net Profit-2.04343.2%410.1%
OPM-1.73%0.69pp1.91pp
NPM-2.85%2.13pp2.29pp
EPS6.59342.3%410.9%
View full financials

Informational and educational content only. Not investment advice.